1A9bnbK

***
INVESTING TOWARDS UNIVERSAL COVERAGE AGAINST NTDS − CHAPTER 2
39
2.7 Moving forward with country programmes
In summary, the investment targeted by this report is about US$ 750 million on average
per year during the period 2015–2020, not counting investments in vector control. This
target represents an increase of about 130% over (more than double) the benchmark cost
of interventions delivered in 2012, based on reported coverage data. Fig. 2.9 gives a sense of
the magnitude of the scale-up required to 2020. If targets are met by 2020, investments in
preventive chemotherapy and treatment and care may decrease to about US$ 460 million on
average per year during 2021–2030.
The Uniting to Combat NTDs coalition has reported that foreign aid in support of the
London Declaration amounted to about US$ 300 million in 2014, not counting vector
control (34). Commitments for the period 2015–2020 are currently projected at less than
US$ 200 million per year. Some aid is destined for regional or global coordination, making
direct comparison with the investment targets difficult. Nonetheless, Fig. 2.9 suggests that
even if aid remains at 2014 levels until 2020 and all of it goes to countries, most of the
investment will still have to come from other sources, increasingly from within endemic
countries.
Fig. 2.9 Foreign aid (2012–2014) and investment targets under the
Roadmap (to 2020) and universal coverage against NTDs
(to 2030), excluding vector control
Constant US$ millions
750
500
250
●
Investment targets
Investment targets for low- and lower-middle-income countries
Additional investments
targeted to 2020
Foreign aid (if 2014 levels maintained)
0
2012
2015
2020
Year
2025
2030
Notes: Foreign aid is reported by the Uniting to Combat NTDs coalition; it excludes the cost of medicines donated
by the pharmaceutical industry and vector control. Two investment targets are presented: one for all endemic
countries, the other for all countries excluding upper-middle-income countries where programmes are expected to
be almost fully funded from domestic sources. The dot in 2012 is based on reported coverage numbers multiplied by
unit cost benchmarks; it can be thought of as a benchmark for expenditures in 2012. All numbers expressed in US$
are constant (real) US$, adjusted to reflect purchasing power in the United States of America in 2015.